BusinessARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate UpdateBy Nasdaq OMXMay 8, 2018, 8:15 PM UTC
BusinessTempus Announces New Initiative to Support Physicians Efforts to Deliver Personalized MedicineBy Nasdaq OMXMay 8, 2018, 5:27 PM UTC
BusinessARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration AgreementBy Nasdaq OMXApr 23, 2018, 12:31 PM UTC
BusinessTreos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal CancerBy Nasdaq OMXApr 11, 2018, 12:15 PM UTC
BusinessTreos Bio Names Gábor Illés as Its Chief Financial OfficerBy Nasdaq OMXApr 3, 2018, 12:15 PM UTC
BusinessARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical TrialBy Nasdaq OMXFeb 26, 2018, 1:00 PM UTC
BusinessTempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and ResearchBy Nasdaq OMXFeb 22, 2018, 3:30 PM UTC
BusinessFilament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel DiseaseBy Nasdaq OMXJan 31, 2018, 1:01 PM UTC
